Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SHE/001367 stock hub

SHE/001367 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/001367is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.5B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/001367

In the news

Latest news · SHE/001367

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E26.7

P25 23.5P50 41.3P75 83.2

ROE9.2

P25 -0.9P50 4.1P75 8.8

ROIC27.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/001367 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

CNY

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	705
Employees Change	42%
Employees Change Percent	6.33
Enterprise value	CNY 2.5B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	CNY 3.5B
Price	CNY 23.52
Price currency	CNY
Rev Per Employee	738,970x
Sector	Healthcare
Sic	2833
Symbol	she/001367
Website	https://www.haisenpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.78%
EV Earnings	18.52x
EV/EBIT	17.58x
EV/EBITDA	14.95x
EV/FCF	50.59x
EV/Sales	4.75x
FCF yield	1.38%
P/B ratio	2.32x
P/E ratio	26.71x
P/S ratio	6.79x
PE Ratio3 Y	25.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.01%
EBITDA Margin	31.47%
FCF margin	9.39%
Gross margin	46.12%
Gross Profit	CNY 240.3M
Gross Profit Growth	22.16%
Gross Profit Growth Q	-1.39%
Gross Profit Growth3 Y	14.85%
Gross Profit Growth5 Y	15.87%
Net Income	CNY 133.6M
Net Income Growth	10.96%
Net Income Growth Q	-7.38%
Net Income Growth3 Y	7.27%
Net Income Growth5 Y	17.93%
Pretax Margin	29.51%
Profit Margin	25.64%
Profit Per Employee	CNY 189,469
ROA	5.6
Roa5y	9.14
ROCE	9.11
ROE	9.19
Roe5y	17.3
ROIC	27.06
Roic5y	41.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	19.29%
Cagr3y	-0.2%
EPS Growth	10.48
EPS Growth Q	-6.27
EPS Growth3 Y	-3.1
EPS Growth5 Y	9.77
FCF Growth	-45.01%
FCF Growth3 Y	-12.03%
FCF Growth5 Y	-4.5%
OCF Growth	-12.23%
OCF Growth Q	-35.03%
OCF Growth3 Y	18.44%
OCF Growth5 Y	18.09%
Revenue Growth	9.87x
Revenue Growth Q	-9.53x
Revenue Growth3 Y	6.06x
Revenue Growth5 Y	16.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.33
Assets	CNY 1.6B
Cash	CNY 1.1B
Current Assets	CNY 1.3B
Current Liabilities	CNY 87.5M
Debt	CNY 7.5M
Debt EBITDA	CNY 0.05
Debt Equity	CNY 0
Debt FCF	CNY 0.15
Equity	CNY 1.5B
Interest Coverage	406.6
Liabilities	CNY 106.7M
Long Term Assets	CNY 350.8M
Long Term Liabilities	CNY 19.3M
Net Cash	CNY 1.1B
Net Cash By Market Cap	CNY 30.04
Net Cash Growth	4.05%
Net Debt EBITDA	CNY -6.48
Net Debt Equity	CNY -0.7
Net Debt FCF	CNY -21.73
Tangible Book Value	CNY 1.4B
Tangible Book Value Per Share	CNY 9.26
WACC	5.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.66
Inventory Turnover	2.51
Net Working Capital	CNY 125.9M
Quick ratio	13.32
Working Capital	CNY 1.2B
Working Capital Turnover	CNY 0.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.43%
Dividend Growth	-31.76%
Dividend Growth Years	0%
Dividend per share	CNY 0.12
Dividend Years	3
Dividend Yield	0.49%
Ex Div Date	2026-05-13
Last Dividend	CNY 0.12
Payout Frequency	Annual
Payout Ratio	13.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	19.28%
200-day SMA	23.99
3Y total return	-0.59%
50-day SMA	24.21
50-day SMA vs 200-day SMA	50over200
All Time High	40.55
All Time High Change	-42%
All Time High Date	2023-04-11
All Time Low	12.12
All Time Low Change	94.04%
All Time Low Date	2024-02-06
ATR	1.03
Beta	0.2
Beta1y	0.21
Beta2y	0.41
Ch YTD	7.15
High	23.76
High52	28
High52 Date	2026-04-16
High52ch	-16%
Low	23.31
Low52	19.67
Low52 Date	2025-05-08
Low52ch	19.58%
Ma50ch	-2.86%
Price vs 200-day SMA	-1.97%
RSI	41.31
RSI Monthly	50.75
RSI Weekly	48.28
Sharpe ratio	0.68x
Sortino ratio	1.28
Total Return	0.07%
Tr YTD	7.15
Tr1m	-8.91%
Tr1w	-0.59%
Tr3m	-2.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 140.7M
Operating Income Growth	21.94
Operating Income Growth Q	-3.98
Operating Income Growth3 Y	9.95
Operating Income Growth5 Y	18.26
Operating margin	27.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,291,504%
Net Borrowing	-1,723,765
Shares Insiders	25.63%
Shares Institutions	0.06%
Shares Out	150,338,200
Shares Qo Q	-1.48%
Shares Yo Y	0.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 48.9M
Average Volume	4,924,999.35x
Bv Per Share	10.03
CAPEX	CNY -114.4M
Ch1m	-8.91
Ch1w	-0.59
Ch1y	18.6
Ch3m	-2.69
Ch3y	-2.45
Ch6m	1.21
Change	0.34%
Change From Open	-0.51
Close	23.44
Days Gap	0.85
Depreciation Amortization	23,266,960
Dollar Volume	58,067,046.2
Earnings Date	2026-08-14
EBIT	CNY 140.7M
EBITDA	CNY 164M
EPS	CNY 0.88
F Score	7
FCF	CNY 48.9M
FCF EV Yield	1.98x
FCF Per Share	CNY 0.33
Financing CF	-15,594,049
Fiscal Year End	December
Founded	1,998
Graham Number	14.09578
Graham Upside	-40.07
Income Tax	CNY 20.1M
Investing CF	-206,610,724
Is Primary Listing	1
Last Earnings Date	2025-10-17
Last Report Date	2026-03-31
Last Split Date	2025-05-20
Last Split Type	Forward
Lynch Fair Value	CNY 15.79
Lynch Upside	-32.86
Ma150	23.64
Ma150ch	-0.51%
Ma20	25.28
Ma20ch	-6.95%
Net CF	-59,300,509
Next Earnings Date	2026-08-14
Open	23.64
P FCF Ratio	72.32
P OCF Ratio	21.66
Payment Date	2026-05-13
Position In Range	46.67
Ppne	229,155,222
Price Date	2026-05-08
Price EBITDA	CNY 21.56
Ptbv Ratio	2.51
Relative Volume	0.5x
Revenue	520,973,850x
Tax By Revenue	3.87x
Tax Rate	13.11%
Tr6m	1.21%
Volume	2,468,837

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/001367 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.12 annual per share

Payout ratio

+13.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.1%

Next ex-dividend date: 2026-05-13

Performance

SHE/001367 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/001367?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

+25.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.4%

Negative means the company is buying back shares.

Technical

SHE/001367 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.3

Neutral momentum band

Price vs 200-day MA

-2.0%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/001367

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/001367 stock rating?

she/001367 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/001367 analysis?

The full report lives at /stocks/she/001367/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/001367?

The latest report frames she/001367 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/001367 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.